Uotila A, Hamblin A, Dumonde D C, Krohn K J
Int Arch Allergy Appl Immunol. 1978;57(3):210-20. doi: 10.1159/000232105.
In this paper we describe experiments to determine whether dialysable extracts of non-lymphoid and lymphoid organs augment lymphocyte transformation in vitro in a manner similar to the augmenting activity of leucocyte dialysates. Human peripheral blood leucocytes were cultured with tuberculin PPD or leucoagglutinin, and dose-related effects of the dialysable extracts on lymphocyte transformation were studied by 125IUdR incorporation. Augmentation of lymphocyte transformation was obtained not only with leucocyte dialysates but also with dialysable extracts of lymphoid and non-lymphoid organs (e.g. spleen, liver, kidney, brain). It is concluded that the agent or agents present in dialysable leucocyte transfer factor preparations, which augment lymphoid transformation in vitro, are widely distributed throughout mammalian tissues.
在本文中,我们描述了一些实验,以确定非淋巴器官和淋巴器官的可透析提取物是否能以类似于白细胞透析液增强活性的方式在体外增强淋巴细胞转化。将人外周血白细胞与结核菌素PPD或白细胞凝集素一起培养,并通过掺入125IUdR研究可透析提取物对淋巴细胞转化的剂量相关效应。不仅白细胞透析液,而且淋巴器官和非淋巴器官(如脾脏、肝脏、肾脏、脑)的可透析提取物都能增强淋巴细胞转化。得出的结论是,可透析白细胞转移因子制剂中存在的、在体外增强淋巴转化的一种或多种因子广泛分布于哺乳动物组织中。